Are hedge funds shorting Vaxcyte (NASDAQ:PCVX) stock? View the latest PCVX short interest ratio, short volume, and more at MarketBeat.

Vaxcyte stock closed at USD 58.92 on September 21, 2026, up 1.36 percent from the prior close. VAX-3

Four biotech companies face key fall readouts that could influence the development and commercial prospects of their pipelines.

Price-action only: Vaxcyte Inc. (PCVX) movements set the tone for institutional models. (PCVX) Price Dynamics and Execution-Aware Positioning

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

Las acciones de Vaxcyte cerraron a 58,92 dólares el 21 de septiembre de 2026, un aumento del 1,36 por ciento. La última instantánea del mercado

Obtenga precios de acciones, noticias, finanzas, conocimientos de la comunidad e ideas comerciales de Vaxcyte Inc (PCVX) en tiempo real. Únase a más de 10 millones de inversores y comerciantes que siguen los mercados en tiempo real en Stocktwits.

Vaxcyte (PCVX) has drawn fresh attention after recent trading left the share price at US$58.13, with short term performance mixed and longer term returns still materially positive for existing holders. Recent trading has cooled some of Vaxcyte’s earlier momentum, with the share price down over the past month but still showing a 90-day share price return of 11.87% and a 1-year total shareholder return of 73.68%, which points to strong longer term sentiment. Scan how Vaxcyte’s recent run...

Las acciones de Vaxcyte cerraron a 60,37 dólares el 17 de septiembre de 2026, un aumento del 2,72 por ciento. Yahoo Finanzas muestra el segundo trimestre de 202